EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Thymic stromal lymphopoietin as a therapeutic target in patients with chronic rhinosinusitis and nasal polyps

Anju T Peters iD, Joseph K Han, Enrico Heffler, Freyja McClenahan, Scott Caveney, Tham T Le, Ayman Megally, Joseph D Spahn, Andrew Foster, Joseph D Sherrill

Clinical and Experimental Immunology · 2025

DOI: 10.1093/cei/uxaf041 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinical and Experimental Immunology, 2025. Verfasst von Anju T Peters und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Allergy and Immunology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA. Hauptthemen laut MEDLINE: Nasal Polyps, Sinusitis, Cytokines, Rhinitis. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 147 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: AstraZeneca, Amgen Inc.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic rhinosinusitis with nasal polyps (CRSwNP) is an inflammatory disorder of the sinonasal mucosa, predominantly characterized by epithelial dysfunction and chronic heterogeneous mucosal inflammation. CRSwNP and asthma are common comorbidities with overlapping pathophysiology, epithelial impairment, and activation of downstream type 2 inflammation. Thymic stromal lymphopoietin (TSLP) is an epithelial cytokine that sits at the top of the immunological cascade and initiates and amplifies type 2-dependent and -independent inflammatory responses. Although the role of TSLP in asthma has been well described, the role of TSLP in CRSwNP has yet to be comprehensively outlined. This review examines the evidence for TSLP as a key factor in CRSwNP pathogenesis. We explore what is known about TSLP expression patterns within the sinonasal mucosa, finding that TSLP expression is increased in patients with CRSwNP compared with healthy patients, and in eosinophilic- versus non-eosinophilic CRSwNP. We discuss the impact of environmental triggers and genetic factors on TSLP expression and activity, as well as other upstream regulators of TSLP signaling. We then consider the known mechanisms and effects of TSLP signaling on the recruitment and activation of various immune and structural cell types in CRSwNP. Finally, we consider the available evidence on the therapeutic potential of targeting TSLP signaling for the treatment of CRSwNP and discuss ongoing trials of promising therapeutic candidates.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Nasal PolypsSinusitisCytokinesRhinitisNasal MucosaHumansThymic Stromal LymphopoietinChronic DiseaseAnimalsSignal TransductionRhinosinusitis

Stichwörter der Autor:innen

cytokineseosinophilsinflammationmucosa

Substanzen

Thymic Stromal LymphopoietinCytokinesTSLP protein, human

Autor:innen und Institutionen

  • Division of Allergy and Immunology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
  • Department of Otolaryngology - Head & Neck Surgery, Eastern Virginia Medical School, Norfolk, VA, USA.
  • Personalized Medicine Asthma and Allergy Unit, IRCCS Humanitas Research Hospital, Milan, Italy.
  • Department of Biomedical Sciences, Humanitas University, Milan, Italy.
  • PharmaGenesis London, London, UK.
  • Global Development, Inflammation, R&D, Amgen, Thousand Oaks, CA, USA.

ORCID-Profile: Anju T Peters

Förderung

  • AstraZeneca
  • Amgen Inc

Zitieren

APA

Peters, A. T., Han, J. K., Heffler, E., McClenahan, F., Caveney, S., Le, T. T., Megally, A., Spahn, J. D., Foster, A., & Sherrill, J. D. (2025). Thymic stromal lymphopoietin as a therapeutic target in patients with chronic rhinosinusitis and nasal polyps. Clinical and Experimental Immunology. https://doi.org/10.1093/cei/uxaf041

Vancouver

Peters AT, Han JK, Heffler E, McClenahan F, Caveney S, Le TT, et al. Thymic stromal lymphopoietin as a therapeutic target in patients with chronic rhinosinusitis and nasal polyps. Clinical and Experimental Immunology. 2025. doi:10.1093/cei/uxaf041

BibTeX
@article{Peters2025,
  author = {Peters, Anju T and Han, Joseph K and Heffler, Enrico and McClenahan, Freyja and Caveney, Scott and Le, Tham T and Megally, Ayman and Spahn, Joseph D and Foster, Andrew and Sherrill, Joseph D},
  title = {Thymic stromal lymphopoietin as a therapeutic target in patients with chronic rhinosinusitis and nasal polyps},
  journal = {Clinical and Experimental Immunology},
  year = {2025},
  doi = {10.1093/cei/uxaf041}
}
Kostenlos starten →